Dr Stewart Hay, CEO | www.therapeuticinnovation.com.au | (03)
9670 7018www.therapeuticinnovation.com.au
Slide 2
Facilitated Therapeutic Product Development Pathways
Capabilities Suite of capabilities enabling development of novel
health technologies from the laboratory bench into clinical trials
34 centres nationally: Drug discovery, Protein Production, Cell
Therapies, Preclinical Testing, Clinical Trials, etc. 6 National
Advisory Committees Funding Running $100M in research
infrastructure projects. Supporting the Australian Government in
Translating Health Discovery into Clinical Application Previously
funded research lead to 26 Phase I/II clinical trials Institutional
Platform Investments into18 hospitals, 11 research institutes &
9 universities Engagement with the pharmaceutical industry,
government agencies and comparable international organisations